Skip to main content
profile image
Selected Works of Dave S.B. Hoon, PhD
Article
KDM6B counteracts EZH2-mediated suppression of IGFBP5 to confer resistance to PI3K/AKT inhibitor treatment in breast cancer.
Molecular Cancer Therapeutics (2018)
  • Wenyu Wang, Genome Institute of Singapore
  • Keng Gat Lim, Genome Institute of Singapore
  • Min Feng, Genome Institute of Singapore
  • Yi Bao, Genome Institute of Singapore
  • Puay Leng Lee, Genome Institute of Singapore
  • Cai Yu, Jinan University
  • Yufeng Chen, Genome Institute of Singapore
  • Hao Zhang, Jinan University
  • Diego M Marzese, Department of Molecular Oncology, John Wayne Cancer Institute
  • Dave S B Hoon
  • Qiang Yu, Genome Institute of Singapore
Link
Disciplines
Publication Date
September 1, 2018
DOI
10.1158/1535-7163.MCT-17-0802
Citation Information
Wenyu Wang, Keng Gat Lim, Min Feng, Yi Bao, et al.. "KDM6B counteracts EZH2-mediated suppression of IGFBP5 to confer resistance to PI3K/AKT inhibitor treatment in breast cancer." Molecular Cancer Therapeutics Vol. 17 Iss. 9 (2018) p. 1973 - 1983
Available at: http://works.bepress.com/dave-hoon/10/